New valve offers hope for High-Risk heart patients
Disease control
Recruiting now
This study tests a new device called the Cardiovalve system to treat severe tricuspid regurgitation, a condition where a heart valve leaks. About 150 people aged 18-84 who are too high-risk for open-heart surgery will receive the valve. The goal is to see if the valve safely redu…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC